Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection
Links shared publicly online about this topic.
- 317total visits
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection
Docefrez (docetaxel) is used to treat metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and hormone refractory metastatic prostate cancer. Includes Docefrez side effects, interactions and indications.
View full resource at drugs.com
Tags: Cancer Medication, Breast Cancer, Metastatic Breast Cancer, Drug, Pharma, FDA, Taxotere
Most Recently Shared on May 5, 2011 at 12:12 am By:
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection: Mumbai, May 4, 2011: Sun Phar... http://bit.ly/jq8d86 #drug
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection
drugs.com — “Docefrez (docetaxel) is used to treat metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and hormone refractory metastatic prostate cancer. Includes Docefrez side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 4, 2011 at 11:19 pm By:
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection - http://bit.ly/kreMHf
Advertisement
